Affordable Access

Publisher Website

Nano-interventions for neurodegenerative disorders

Authors
Journal
Pharmacological Research
1043-6618
Publisher
Elsevier
Publication Date
Volume
62
Issue
2
Identifiers
DOI: 10.1016/j.phrs.2010.02.004
Keywords
  • Blood–Brain Barrier
  • Endocytosis
  • Transporters
  • Nanoparticles
  • Toxicity
Disciplines
  • Medicine
  • Pharmacology

Abstract

Abstract With an increase in lifespan and changing population demographics, the incidence of central nervous system (CNS) diseases is expected to increase significantly in the 21st century. Contrary to common belief, it is recognized that neurodegenerative diseases may be multisystemic in nature and this presents numerous difficulties for the potential treatment of these disorders. This review focuses on applications in the nano-delivery of therapeutic agents across the blood–brain barrier. We explore various types of nanoparticles, ranging from polymerics to liposomes. A brief discussion of the pharmacokinetic parameters and specific targeting strategies of these nanoparticles follows, presenting suggestions for the mechanisms of cellular and intracellular uptake and possible toxicity considerations of nanoparticles.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Nanotechnology for neurodegenerative disorders

on Nanomedicine Nanotechnology Bi...

Advances in the treatment of neurodegenerative dis...

on Annals of the New York Academy... January 2010

Treatment of neurodegenerative disorders with radi...

on Annals of the New York Academy... December 2007
More articles like this..